Advertisement
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com.jpg)
Document › Details
Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Launches Equity Placement [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen.
![]() |
Organisation | Biocartis Group N.V. (Euronext Brussels: BCART) |
Group | Biocartis (Group) | |
Organisation 2 | Berenberg (Group) | |
![]() |
Product | Idylla™ molecular diagnostics system |
Product 2 | investment banking | |
![]() |
Index term | Biocartis–SEVERAL: investment, 201901 private placement €55.5m of 5m new shares at €11.1/share |
![]() |
Person | Degrave, Renate (Biocartis 201611 Manager CorpComm + IR) |
Original document
accessed by [iito] on 2018-01-23
Record changed: 2019-01-24 |
Advertisement
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
More documents for Biocartis (Group)
- [1] Biocartis Group N.V.. (6/1/19). "Press Release: Biocartis and Kite Sign Agreement for Development of Assays Supporting Kite's Therapies". Mechelen....
- [2] Biocartis Group N.V.. (4/25/19). "Press Release: Biocartis Q1 2019 Business Update". Mechelen....
- [3] Biocartis Group N.V.. (4/23/19). "Press Release: Biocartis Announces Global Collaboration with Covance". Mechelen....
- [4] Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Successfully Raises EUR 55.50 Milion in an Equity Placement [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen....
- [5] Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Upsizes Its Equity Placement Due to Significant Demand [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen....
- [6] Biocartis Group N.V.. (12/3/18). "Press Release: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test". Redwood City, CA & Mechelen....
- [7] Biocartis Group N.V.. (11/29/18). "Press Release: Biocartis and AstraZeneca Enter into Agreement Aimed at Faster Lung Cancer Biomarker Results". Mechelen....
- [8] Biocartis Group N.V.. (9/3/18). "Press Release: Biocartis and Wondfo Announce Joint Venture for Commercialization of Idylla Platform in China". Mechelen & Guangzhou....
- [9] Biocartis Group N.V.. (8/28/18). "Press Release: Biocartis Obtains Exclusive Worldwide License Rights for EGFR Ectodomain Mutations Determining Response to Targeted Colorectal Cancer Therapy". Mechelen....
- [10] Biocartis Group N.V.. (7/17/18). "Press Release: Biocartis Launches Innovative Idylla MSI Assay". Mechelen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top